CDC20 Gene Cell Cycle Disorder NGS Genetic DNA Test
Comprehensive Genetic Analysis for Cell Cycle Regulation Disorders
The CDC20 Gene Cell Cycle Disorder NGS Genetic DNA Test represents a breakthrough in precision medicine, offering comprehensive analysis of the CDC20 gene’s role in cell division regulation. This advanced genetic test utilizes next-generation sequencing technology to identify mutations that disrupt normal cell cycle progression, potentially leading to uncontrolled cellular growth and cancer development.
What Does the CDC20 Gene Test Measure?
This sophisticated genetic analysis specifically targets the CDC20 (Cell Division Cycle 20) gene, which encodes a crucial regulatory protein in the anaphase-promoting complex/cyclosome (APC/C). The test detects:
- Point mutations and single nucleotide variants in the CDC20 gene
- Insertions and deletions affecting gene function
- Copy number variations and structural abnormalities
- Regulatory region mutations impacting gene expression
- Pathogenic variants associated with cell cycle dysregulation
Who Should Consider This Genetic Test?
This test is particularly recommended for individuals experiencing:
- Family history of multiple cancers across generations
- Early-onset cancer diagnoses in family members
- Unexplained tumor growth or abnormal cell proliferation
- Genetic predisposition to cell cycle disorders
- Multiple primary cancers in the same individual
- Congenital abnormalities suggesting cell division defects
- Previous inconclusive genetic testing results
Clinical Benefits of CDC20 Genetic Testing
Undergoing CDC20 genetic analysis provides numerous advantages for proactive healthcare management:
- Early Cancer Detection: Identifies genetic predisposition before symptom onset
- Personalized Treatment Planning: Guides targeted therapy selection based on genetic profile
- Family Risk Assessment: Enables genetic counseling for at-risk relatives
- Preventive Strategies: Supports implementation of early screening protocols
- Reproductive Planning: Informs family planning decisions for hereditary conditions
- Peace of Mind: Provides clarity about genetic cancer risks
Understanding Your Test Results
Your CDC20 genetic test results will be carefully interpreted by our expert genetic counselors and oncologists:
- Positive Result: Indicates presence of pathogenic CDC20 mutation requiring specialized monitoring and management
- Negative Result: No detected mutations, though continued routine screening may be recommended
- Variant of Uncertain Significance: Requires additional family studies and ongoing research correlation
- Benign Variants: Common genetic variations not associated with increased cancer risk
All results include comprehensive genetic counseling to ensure complete understanding and appropriate next steps.
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic testing facilities ensures accessible, reliable service nationwide.
Take Control of Your Genetic Health Today
Don’t wait to gain crucial insights into your genetic cancer risk profile. Our CDC20 Gene Cell Cycle Disorder NGS Genetic DNA Test provides the comprehensive analysis needed for informed healthcare decisions. Schedule your appointment today by calling our genetic specialists at +1(267) 388-9828 or book your test online through our secure patient portal.
With results typically available within 3-4 weeks and sample collection options including blood, extracted DNA, or FTA card blood drops, getting tested has never been more convenient. Take the first step toward proactive genetic health management and book your CDC20 genetic test now.
